Optimi Health Corp. (CSE:OPTI)
Canada · Delayed Price · Currency is CAD 4.840
+0.090 (1.89%)
Oct 22, 2026, 9:41 AM EDT
Optimi Health Earnings Call Transcripts
Fiscal Year 2026
-
Australian distribution is active, with clinic expansion targeted over the next year. Phase II psilocybin and phase III MDMA programs, research-focused Ibogaine supply by year-end, and policy shifts form key catalysts.
-
Currently commercial with psilocybin and MDMA products in Australia and Canada, the company is expanding globally as regulatory frameworks evolve. Insurance reimbursement and rapid clinic adoption in Australia highlight strong market traction, while U.S. and Canadian policy shifts signal further growth opportunities.